EM Managers - Most Avoided Stocks
• The 830 stocks in the benchmark MSCI Emerging Market Index all represent legitimate investments for global EM active managers. Whilst publicly...
338 Views
The Disconnect Is Growing
Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...
604 Views
Alpha Generation from Share Buybacks in Korea (2017 YTD)
In this report, we have identified 26 stocks in the Korean stock market that have announced share buyback programs so far in 2017. These stocks...
1.3k Views
Update on the Put Back Option Clause for IPOs in the Korea Stock Market
This report is an update on the implementation of the "put-back option clause" for IPOs in the Korea Stock Market (for companies applying under the...
399 Views
Celltrion Healthcare IPO - Summary on Last Week's IPO Roadshow in HK & Singapore
Celltrion Healthcare just completed the pre-IPO roadshows in Hong Kong and Singapore last week. The company officials met about 15 institutional...
346 Views